MCL-1 inhibition in cancer treatment

被引：111
|
作者：
Xiang, Weiguo [1 ]
Yang, Chao-Yie [1 ,2 ]
Bai, Longchuan [1 ,2 ]
机构：
[1] Univ Michigan, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Rogel Canc Ctr, 1600 Huron Pkwy,Bldg 520-G352, Ann Arbor, MI 48109 USA
来源：
ONCOTARGETS AND THERAPY | 2018年 / 11卷
关键词：
BCL-2; BAX; BAK; apoptosis; BH3; mimetics; SMALL-MOLECULE INHIBITOR; TARGETING MCL-1; DOWN-REGULATION; GAMBOGIC ACID; DIFFERENTIAL REGULATION; BH3-ONLY PROTEINS; COPY-NUMBER; IN-VITRO; BCL-2; APOPTOSIS;
D O I：
10.2147/OTT.S146228
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Myeloid cell leukemia-1 (MCL-1), a member of antiapoptotic BCL-2 family proteins, is a key regulator of mitochondrial homeostasis. Frequent overexpression of MCL-1 in human primary and drug-resistant cancer cells makes it an attractive cancer therapeutic target. Significant progress has been made in the development of small-molecule MCL-1 inhibitors in recent years, and three MCL-1 selective inhibitors have advanced to clinical trials. This review briefly discusses recent advances in the development of small molecules targeting MCL-1 for cancer therapy.
引用
收藏
页码：7301 / 7314
页数：14
相关论文
共 50 条
  • [41] Mcl-1 Expression in Cholangiocarcinoma
    Nakanishi, Y.
    Hashida, H.
    Miyauchi, Y.
    Yoshimura, M.
    Yoshida, M.
    Yoshitomi, M.
    Tada, M.
    Ueda, S.
    Terajima, H.
    Osaki, N.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : S88 - S88
  • [42] Unraveling MCL-1 degradation
    Opferman, J. T.
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (08): : 1260 - 1262
  • [43] Regulation of apoptosis by Mcl-1
    Edwards, S. W.
    Thomas, L. W.
    Lam, C. W.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 35 - 35
  • [44] Seeking a MCL-1 inhibitor
    G Brumatti
    P G Ekert
    Cell Death & Differentiation, 2013, 20 : 1440 - 1441
  • [45] Mcl-1 Ubiquitination and Destruction
    Inuzuka, Hiroyuki
    Fukushima, Hidefumi
    Shaik, Shavali
    Liu, Pengda
    Lau, Alan W.
    Wei, Wenyi
    ONCOTARGET, 2011, 2 (03) : 239 - 244
  • [46] MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
    Young, Adelaide I. J.
    Law, Andrew M. K.
    Castillo, Lesley
    Chong, Sabrina
    Cullen, Hayley D.
    Koehler, Martin
    Herzog, Sebastian
    Brummer, Tilman
    Lee, Erinna F.
    Fairlie, Walter D.
    Lucas, Morghan C.
    Herrmann, David
    Allam, Amr
    Timpson, Paul
    Watkins, D. Neil
    Millar, Ewan K. A.
    O'Toole, Sandra A.
    Gallego-Ortega, David
    Ormandy, Christopher J.
    Oakes, Samantha R.
    BREAST CANCER RESEARCH, 2016, 18
  • [47] Seeking a MCL-1 inhibitor
    Brumatti, G.
    Ekert, P. G.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (11): : 1440 - 1441
  • [48] Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance
    Bolesta, Elzbieta
    Pfannenstiel, Lukas W.
    Demelash, Abeba
    Lesniewski, Mathew L.
    Tobin, Megan
    Schlanger, Simon E.
    Nallar, Shreeram C.
    Papadimitriou, John C.
    Kalvakolanu, Dhan V.
    Gastman, Brian R.
    MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (10) : 1879 - 1892
  • [49] MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
    Adelaide I. J. Young
    Andrew M. K. Law
    Lesley Castillo
    Sabrina Chong
    Hayley D. Cullen
    Martin Koehler
    Sebastian Herzog
    Tilman Brummer
    Erinna F. Lee
    Walter D. Fairlie
    Morghan C. Lucas
    David Herrmann
    Amr Allam
    Paul Timpson
    D. Neil Watkins
    Ewan K. A. Millar
    Sandra A. O’Toole
    David Gallego-Ortega
    Christopher J. Ormandy
    Samantha R. Oakes
    Breast Cancer Research, 18
  • [50] The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
    Stewart M.L.
    Fire E.
    Keating A.E.
    Walensky L.D.
    Nature Chemical Biology, 2010, 6 (8) : 595 - 601
12345